Bone marrow microenvironment in fanconi anemia: a prospective functional study in a cohort of fanconi anemia patients.

Fanconi anemia (FA) is a rare condition due to the genetic inactivation of the FA/BRCA pathway. During childhood, most FA patients display progressive bone marrow failure (BMF), the mechanism of which has not been clarified to date. We analyzed BM mesenchymal stem cells (MSCs) from a series of 20 FA patients with BMF (patient median age 12.5 years old, range 7-34). Expression of FANCD2 and sensitivity to mitomycin C, differentiation capacities, and hematopoiesis-supporting abilities, as well as proliferation, cell senescence, and telomere length were assessed. FA MSCs demonstrated hypersensitivity to mitomycin C compared to control MSCs, as expected for FA cells. FA MSCs had normal immunophenotype, support long-term culture of hematopoietic stem cells (HSCs), and display normal differentiation capacities. Telomere loss during cell aging was similar for FA and control MSCs. However, FA MSCs showed reduced long-term proliferation ability, higher stem cell factor and interleukin-6 levels, and increased expression of senescent-associated beta-galactosidase compared to normal MSCs, suggesting a potential role of the BM microenvironment in long-term BMF.

[1]  F. Sigaux,et al.  Detection of somatic mosaicism and classification of Fanconi anemia patients by analysis of the FA/BRCA pathway. , 2005, Blood.

[2]  D. Clapp,et al.  Fanconi anemia type C-deficient hematopoietic stem/progenitor cells exhibit aberrant cell cycle control. , 2003, Blood.

[3]  J. Dick,et al.  Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. , 1999, Experimental hematology.

[4]  F. Calvo,et al.  Decreased IL‐1β and TNFα secretion in long‐term bone marrow culture supernatant from Fanconi's anaemia patients , 1996 .

[5]  M. Tischkowitz,et al.  Fanconi anaemia and leukaemia – clinical and molecular aspects , 2004, British journal of haematology.

[6]  T. Onega,et al.  Constitutive and induced expression of hematopoietic growth factor genes by fibroblasts from children with Fanconi anemia. , 1993, Experimental hematology.

[7]  H. Ichijo,et al.  Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1. , 2005, Blood.

[8]  J. Klein,et al.  Bone marrow transplantation for Fanconi anemia. , 1995, Blood.

[9]  F. Galibert,et al.  The expression of cytokine and cytokine receptor genes in long‐term bone marrow culture in congenital and acquired bone marrow hypoplasias , 1993, British journal of haematology.

[10]  Hans Joenje,et al.  The genetic and molecular basis of Fanconi anemia. , 2009, Mutation research.

[11]  F. Rosselli.  Fanconi anaemia syndrome and apoptosis: state of the art , 1998, Apoptosis.

[12]  R. Moses,et al.  Positional cloning of a novel Fanconi anemia gene, FANCD2. , 2001, Molecular cell.

[13]  K. Pollok,et al.  Mesenchymal stem/progenitor cells promote the reconstitution of exogenous hematopoietic stem cells in Fancg-/- mice in vivo. , 2009, Blood.

[14]  E. Gluckman,et al.  Long‐term bone marrow culture in Fanconi's anaemia , 1993, British journal of haematology.

[15]  M. Buchwald,et al.  Multiple inhibitory cytokines induce deregulated progenitor growth and apoptosis in hematopoietic cells from Fac-/- mice. , 1998, Blood.

[16]  I. Dokal.  Inherited bone marrow failure syndromes , 2011 .

[17]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[18]  A. Auerbach.  Fanconi anemia diagnosis and the diepoxybutane (DEB) test. , 1993, Experimental hematology.

[19]  F. Jirik,et al.  Increased sensitivity of Fancc-deficient hematopoietic cells to nitric oxide and evidence that this species mediates growth inhibition by cytokines. , 2003, Blood.

[20]  J. Soulier,et al.  Hematopoietic progenitor cel harvest and functionality in Fanconi anemia patients. , 2002, Blood.

[21]  A. Berns,et al.  Mice with a targeted disruption of the Fanconi anemia homolog Fanca. , 2000, Human molecular genetics.

[22]  A. D’Andrea,et al.  A novel diagnostic screen for defects in the Fanconi anemia pathway. , 2002, Blood.

[23]  C. Mathew,et al.  Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. , 2004, Blood.

[24]  J. Soulier,et al.  Phenotypic and functional characterization of bone marrow mesenchymal stem cells derived from patients with multiple myeloma , 2007, Leukemia.